Literature DB >> 31680608

Age- and Sex-Specific Increases in Stimulant Prescribing Rates-California, 2008-2017.

Iraklis Erik Tseregounis1, Susan L Stewart1, Andrew Crawford1, Brandon D L Marshall2, Magdalena Cerdá3, Aaron B Shev1, Stephen G Henry1.   

Abstract

Objective: To describe trends in prevalent and incident stimulant prescribing between 2008 and 2017 in California. Method: Statewide trends were estimated by age and sex category for prevalent (any) and incident (no prescriptions in the preceding 2 years) stimulant prescribing while adjusting for area-level covariates.
Results: Prevalent prescribing rates increased by 126%, while incident prescribing increased 23%. Patients aged 25 to 44 years experienced over 200% increases in prevalent prescribing and 34% to 55% increases in incident prescribing. Among patients older than 25, women had consistently higher prescribing rates than men. ZIP code tabulation areas with the largest minority populations had the lowest baseline prescribing rates but experienced the greatest annual prescription rate increases.
Conclusion: Adult stimulant prescribing increased substantially for early working aged adults. Prescription rates were greater for women than men.

Entities:  

Keywords:  adult ADHD treatment; medication trends; prescription; stimulants

Mesh:

Substances:

Year:  2019        PMID: 31680608      PMCID: PMC6937374          DOI: 10.1177/1087054719883008

Source DB:  PubMed          Journal:  J Atten Disord        ISSN: 1087-0547            Impact factor:   3.256


  25 in total

Review 1.  Recent Trends in Stimulant Usage.

Authors:  Daniel J Safer
Journal:  J Atten Disord       Date:  2015-10-20       Impact factor: 3.256

2.  Controlled Substance Prescribing Patterns--Prescription Behavior Surveillance System, Eight States, 2013.

Authors:  Leonard J Paulozzi; Gail K Strickler; Peter W Kreiner; Caitlin M Koris
Journal:  MMWR Surveill Summ       Date:  2015-10-16

3.  Mental health in the United States. Prevalence of diagnosis and medication treatment for attention-deficit/hyperactivity disorder--United States, 2003.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2005-09-02       Impact factor: 17.586

4.  Patterns and predictors of attention-deficit/hyperactivity disorder persistence into adulthood: results from the national comorbidity survey replication.

Authors:  Ronald C Kessler; Lenard A Adler; Russell Barkley; Joseph Biederman; C Keith Conners; Stephen V Faraone; Laurence L Greenhill; Savina Jaeger; Kristina Secnik; Thomas Spencer; T Bedirhan Ustün; Alan M Zaslavsky
Journal:  Biol Psychiatry       Date:  2005-06-01       Impact factor: 13.382

5.  Trends in office-based treatment of adults with stimulants in the United States.

Authors:  Mark Olfson; Carlos Blanco; Shuai Wang; Laurence L Greenhill
Journal:  J Clin Psychiatry       Date:  2013-01       Impact factor: 4.384

6.  Racial and Ethnic Disparities in ADHD Diagnosis and Treatment.

Authors:  Tumaini R Coker; Marc N Elliott; Sara L Toomey; David C Schwebel; Paula Cuccaro; Susan Tortolero Emery; Susan L Davies; Susanna N Visser; Mark A Schuster
Journal:  Pediatrics       Date:  2016-08-23       Impact factor: 7.124

7.  Age trends in rates of substance use disorders across ages 18-90: Differences by gender and race/ethnicity.

Authors:  Sara A Vasilenko; Rebecca J Evans-Polce; Stephanie T Lanza
Journal:  Drug Alcohol Depend       Date:  2017-09-14       Impact factor: 4.492

8.  The lifetime impact of attention deficit hyperactivity disorder: results from the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC).

Authors:  S Bernardi; S V Faraone; S Cortese; B T Kerridge; S Pallanti; S Wang; C Blanco
Journal:  Psychol Med       Date:  2011-08-16       Impact factor: 7.723

9.  Trends in medication treatment for ADHD.

Authors:  Lon Castle; Ronald E Aubert; Robert R Verbrugge; Mona Khalid; Robert S Epstein
Journal:  J Atten Disord       Date:  2007-05       Impact factor: 3.256

10.  Overdose Deaths Involving Opioids, Cocaine, and Psychostimulants - United States, 2015-2016.

Authors:  Puja Seth; Lawrence Scholl; Rose A Rudd; Sarah Bacon
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2018-03-30       Impact factor: 17.586

View more
  3 in total

1.  State-Level Estimates of the Prevalence of Parent-Reported ADHD Diagnosis and Treatment Among U.S. Children and Adolescents, 2016 to 2019.

Authors:  Melissa L Danielson; Joseph R Holbrook; Rebecca H Bitsko; Kimberly Newsome; Sana N Charania; Russell F McCord; Michael D Kogan; Stephen J Blumberg
Journal:  J Atten Disord       Date:  2022-05-22       Impact factor: 3.196

2.  Trends in stimulant dispensing by age, sex, state of residence, and prescriber specialty - United States, 2014-2019.

Authors:  Amy R Board; Gery Guy; Christopher M Jones; Brooke Hoots
Journal:  Drug Alcohol Depend       Date:  2020-09-15       Impact factor: 4.492

3.  Changes in Provider Type and Prescription Refills Among Privately Insured Children and Youth With ADHD.

Authors:  Laura C Hart; Scott D Grosse; Melissa L Danielson; Rebecca A Baum; Alex R Kemper
Journal:  J Atten Disord       Date:  2020-09-18       Impact factor: 3.256

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.